Article result template
I'm a little template short and blank. I link to void and keep hidden out.
2024-12-19T10:04:43+0000
I'm a little template short and blank. I link to void and keep hidden out.
2024-12-19T10:04:43+0000
Trial results from Eli Lilly add to a growing body of evidence that suggests GLP-1 drugs, which include treatments like Lilly’s Mounjaro and Novo Nordisk’s Wegovy, have medical benefits beyond diabetes and weight loss.
2024-04-17T16:11:00+0100
Novo Nordisk has surpassed Tesla in terms of market cap after positive early trial data for its hotly awaited new obesity drug. IGTV's Angeline Ong takes a closer look at a weight-loss drug sector set to be worth $100 bln by 2030.
2024-03-08T14:55:35+0000
Global syringe-filling facilities are struggling to cope with rising demand for anti-obesity drugs, which require injection pens.
2023-12-28T09:10:57+0000